stroke, biomarkers, neurorepair, neuroprotection, stroke prevention, acute phase, thrombolysis
Del Río-Espínola A, Fernández-Cadenas I, Giralt D, Quiroga A, Gutiérrez-Agulló M, Quintana M, Fernández-Álvarez P, Domingues-Montanari S, Mendióroz M, Delgado P, Turck N, Ruíz A, Ribó M, Castellanos M, Obach V, Martínez S, Freijo MM, Jiménez-Conde J, Cuadrado-Godia E, Roquer J, Chacón P, Martí-Fábregas J, Sánchez JC; the GRECOS Investigators, Montaner J.
A predictive clinical-genetic model of tissue plasminogen activator response in acute ischemic stroke.
Ann Neurol. 2012;72(5):716-729.
Montaner J, Perea-Gainza M, Delgado P, Ribó M, Chacón P, Rosell A, Quintana M, Palacios ME, Molina CA, Alvarez-Sabín J.
Etiologic Diagnosis of Ischemic Stroke Subtypes Using Plasma Biomarkers.
Stroke. 2008;39:2280-2287
Morancho A, Hernández-Guillamon M, Boada C, Barceló V, Giralt D, Ortega L,
Montaner J, Rosell A.
Cerebral ischaemia and matrix metalloproteinase-9 modulate the angiogenic function of early and late outgrowth endothelial progenitor cells.
J Cell Mol Med. 2013 Aug 15. doi: 10.1111/jcmm.12116